There could be a number of potentially interesting developments and press releases coming from VODG in calendar 2011. If the competitive advantages of its VitroGrow culture media are as distinct as indicated, it is probably only a matter of time before the product begins to gain much more significant traction in the market.
An item from the 10-K filed on Friday, pertaining to the VitroGrow product line.....
Based on language in the last 10-Q and the 10-K, it appears VODG is very close to entering into a license agreement for its fertility drug technology. From the 10-Q filed in September.....
And now two items from the 10-K, which strongly suggest progress is being made toward a license agreement......
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.